Astria Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATXS and other ETFs, options, and stocks.

About ATXS

Astria Therapeutics, Inc. engages in the discovery, development, and commercialization of novel therapeutics. Its lead product candidate is STAR-0215, which is intended to treat Hereditary Angioedema, a rare genetic disorder characterized by severe, recurrent, unpredictable, painful, and sometimes life-threatening swelling in the face, limbs, abdomen, and airway. 

CEO
Jill C. Milne
CEOJill C. Milne
Employees
29
Employees29
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2008
Founded2008
Employees
29
Employees29

ATXS Key Statistics

Market cap
119.37M
Market cap119.37M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
155.23K
Average volume155.23K
High today
$9.32
High today$9.32
Low today
$8.77
Low today$8.77
Open price
$9.03
Open price$9.03
Volume
94.50K
Volume94.50K
52 Week high
$10.70
52 Week high$10.70
52 Week low
$2.36
52 Week low$2.36

ATXS Earnings

-$1.18
-$0.79
-$0.39
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 9, After Hours
ActualExpected Nov 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.